Research suggests several beneficial mechanisms: Improved insulin sensitivity : Insulin resistance is a key driver of PCOS symptoms, and GLP-1 medications can enhance insulin action Weight loss effects : Even modest weight reduction (510% of body weight) can restore ovulation and regular cycles in women with PCOS [17] [18] Reduced androgen levels : Weight loss and improved insulin sensitivity often lead to decreased testosterone and other androgens Restoration of ovulation : Some women with PCOS who previously had absent periods may begin ovulating regularly NICE Clinical Knowledge Summary on PCOS recommends lifestyle modification and weight loss as first-line interventions for overweight women with the condition
The longer answer which is what the rest of this guide is about explains why, what's actually in the patches, what the science says about transdermal weight loss, and what works instead if you're serious about losing weight
PMID 33831374
Appetite effects, if they occur, typically emerge around weeks 3 to 4
This material is not intended for human or veterinary use, medical applications, diagnostic procedures, or therapeutic administration
Weight loss results At 68 weeks, the mean percent change in body weight was: Retatrutide 12 mg: -28.7% , equivalent to approximately 32.3 kg (71.2 lb) of absolute loss at baseline averages
